IC
SHPH icon

Ikarian Capital’s Shuttle Pharmaceuticals SHPH Stock Holding History

Ikarian Capital’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46.8K Hold
6,899
– – ﹤0.01% 155
2025
Q4 		$124K Buy
+6,899
New +$176K 0.01% 159

Other funds holding SHPH

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
KFA
Kelleher Financial Advisors New York $395M AUM 12.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ikarian Capital's SHPH Position: Q1 2026 in Review

Ikarian Capital held its Shuttle Pharmaceuticals (SHPH) position steady in Q1 2026 at 6,899 shares worth $46.8K. The position accounts for ﹤0.01% of the portfolio, ranked #155.

Ikarian Capital first reported a position in SHPH in Q4 2025 and has held it in 2 quarters since. The position peaked at $124K in Q4 2025. 8 funds tracked by Wall St. Rank hold SHPH as of Q1 2026.

  • Ikarian Capital held 6,899 shares of Shuttle Pharmaceuticals worth $46.8K as of Q1 2026.
  • Ikarian Capital left its Shuttle Pharmaceuticals share count unchanged in Q1 2026.
  • Shuttle Pharmaceuticals made up ﹤0.01% of Ikarian Capital's portfolio in Q1 2026, its #155 holding.
  • Ikarian Capital first reported a position in Shuttle Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Ikarian Capital's Shuttle Pharmaceuticals position peaked at $124K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.